Skip to main content
Fig. 5 | BMC Complementary Medicine and Therapies

Fig. 5

From: Thymoquinone, piperine, and sorafenib combinations attenuate liver and breast cancers progression: epigenetic and molecular docking approaches

Fig. 5

Effect of thymoquinone (TQ), piperine (PIP), and sorafenib (SOR) and their combinations on cell cycle distribution of HepG2 cells. Cell cycle analysis was performed using flow cytometry. Representative histograms are shown (A), Percentage of cells in each cell cycle phases (B). Data are expressed as the mean ± SEM; n = 3. Means within columns carrying * are significantly different at (p ˂0.05), ** (p ˂ 0.01), *** (p ˂ 0.001) and **** (p ˂ 0.0001)

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us